AnaptysBio, Inc. (ANAB) Tops Q4 EPS by 71c
Tweet
Share
E-mail
Get Alerts ANAB Hot Sheet
Join SI Premium – FREE
AnaptysBio, Inc. (NASDAQ: ANAB) reported Q4 EPS of $1.58, $0.71 better than the analyst estimate of $0.87. Revenue for the quarter came in at $108.25 million versus the consensus estimate of $87.09 million.
For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Freedom Broker Starts Intrepid Potash (IPI) at Buy
- Potomac Bancshares, Inc. (PTBS) Declares $0.15 Quarterly Dividend; 2.5% Yield
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
